期刊文献+

宫颈鳞癌组织中MCM5的表达及临床意义 被引量:1

Expression of MCM5 in Squamous Cell Carcinoma of the Cervix and Its Clinical Significance
暂未订购
导出
摘要 【目的】探讨微小染色体维持蛋白5(MCM5)在宫颈鳞癌和宫颈上皮内瘤(cIN)变中的表达及其临床意义。【方法】采用免疫组化法检测MCM5在66例宫颈鳞癌及90例CIN中的表达,通过标记指数(LI)计算MCM5在宫颈病变中表达情况,并分析其与临床病理学特征之间的关系。【结果IMCM5的表达从CIN到宫颈鳞癌逐渐增高:在CINⅠ,CINⅡ,CINⅢ,宫颈鳞癌中LI中位数分别为36.45%,60.43%,79.52%,90.34%。4组间比较差异有统计学意义(P〈0.01);在宫颈鳞癌高、中、低分化组中MCM5表达逐渐升高,差异有统计学意义(P〈0.01),而在FIGO分期、年龄、淋巴结是否转移各组中差异均无统计学意义(P〉0.05)。【结论]MCM5是一种新型的细胞增殖标志物,可以作为宫颈病变预后的参考指标,其表达水平与宫颈鳞癌分化程度有关。 [Objective] To explore the expression of minute chromosome maintenance protein 5(MCM5) in squamous cell carcinoma of the cervix and cervical intraepithelial neoplasia(CIN) and its clinical significance. [Methods]Immunohistochemistry staining method was used to detect the expression of MCM5 in 66 cases of cervical squamous cell carcinoma and 90 cases of CIN. The relationship between the expression of MCM5 and clinical pathological characteristics was analyzed. [Results]The expression of MCM5 increased from CIN to cervical squamous cell carcinoma. The LI median of MCM5 in CIN Ⅰ, CIN Ⅱ, CIN Ⅲ and cervical squanous cell carcinoma was 36.45%, 60.43%, 79.52% and 90.34%, respectively, and the difference among 4 groups had statistical significance( P 〈0.01). But there was no statistical significance in FIGO stage, age and lymph node metastasis among 4 groups( P 〉0.05). [Conclusion]MCM5 is a new indicator of cell proliferation, and can he served as a reference index. Its expression is associated with differentiation of cervical squamous cell carcinoma.
出处 《医学临床研究》 CAS 2010年第12期2204-2206,共3页 Journal of Clinical Research
关键词 鳞状细胞/病理学 宫颈肿瘤/病理学 carcinoma, squamous cell/PA cervix neoplasms/PA
  • 相关文献

参考文献10

  • 1Maine GT,Sinha P,Tye BK.Mutants of s,cerevisiae defective in The maintenance of miniehromosomes[J].Genetics,1984,106(3):365-385.
  • 2Forsburg SL.Eukaryotic MCM proteins:beyond replication initiation[J1.Microbiol Mol Biol Rev,2004,68 (1):109-131.
  • 3Forsburg SL.The MCM helicase:linking checkpoints to the replication fork[J].Biochem Soc Trans,2008,36 (Pt 1):114-119.
  • 4Snyder M,He W,Zhang J J.The DNA replication factor MCM5 is essential for Statl-mediated transcriptional activation[J].Proc Natl Acad Sci USA,2005,102 (41):14539-14544.
  • 5张曼,安成,白炎,张秀敏,郝林,张敏,许华林.检测尿脱落细胞中微小染色体维持蛋白5基因表达对膀胱癌的意义[J].中华检验医学杂志,2003,26(2):101-103. 被引量:10
  • 6张卫星,郑树,郑涛.尿脱落细胞中存活素和微小染色体支持蛋白5检测在膀胱癌诊断中的价值[J].中华泌尿外科杂志,2005,26(4):233-236. 被引量:6
  • 7Schaarschmidt D,Ladenburger EM,Keller C,et al.Human MCM proteins at a replication origin during the G1 to S phase transtion[J].Nucleic Acids Res,2002,30(19):4176-4185.
  • 8Stoler MH,Schiffman M.Interobserver reproducibility of cervical cytologic and histologic interpretations:realistic estimates from the ASCUS-LSIL triage study[J].JAMA,2001,285:1500-1505.
  • 9Freeman A,Morris LS,Mills AD,et al.Minichromosome maintenance proteins as biological markers of dysplasia and malignancy[J].Clin Cancer Res,1999,5(8):2121-2132.
  • 10Willams GH,Romanowski P,Mills AD,et al.Improved cervical smear assessment using antibodies against proteins that regulate DNA replication[J].Proc Natl Acad Sci USA,1998(95):14932-14937,.

二级参考文献14

  • 1Park YN, Chae KJ, Kim YB. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer,2001,92:2733-2738.
  • 2Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis.Genes Dev, 1999,13:239-252.
  • 3Ambrosini G,Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3:917-921.
  • 4Swana H S, Grossman D, Anthony JN ,et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med, 1999,341:452-453.
  • 5Smith SD, Wheeler MA, Plescia J, et al. Urine detection of survivin and diagnosis of badder cancer. JAMA ,2001,285:324-328.
  • 6Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res, 1999,5:2121-2132.
  • 7Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA, 1998,95 : 14932-14937.
  • 8Stoeber K, Swinn R, Prevost AT, et al. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst,2002 ,94 :1071-1079.
  • 9Sanchez-Carbayo M, Herrero E, Megias J, et al. Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen,tissue polypeptide antigen and NMP22 to detect bladder cancer. J Urol, 1999,162 : 1951.
  • 10吴忠,张元芳,刘定干,李载平,贺斌.尿脱落细胞CD_(44)基因变异表达产物对膀胱癌诊断价值的研究[J].临床泌尿外科杂志,1997,12(4):235-238. 被引量:3

共引文献13

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部